SYP and Alzheimer disease: Studies in Alzheimer's disease (AD) rats have demonstrated that increased levels of brain-derived neurotrophic factors and the administration of AM206 and miR-206 blocker, both may enhance the expression of hippocampal synaptophysin and neurogenesis and cognitive function [17].